Serarslan, GamzeAksakal, Metin2024-09-192024-09-1920152299-0631https://doi.org/10.17420/ap6103.08https://hdl.handle.net/20.500.12483/15352Cutaneous leishmaniasis is a protozoan infectious disease and widespread in Mediterranean basin including Turkey. Lesions usually start with erythematous papules, gradually enlarges and afterwards it ulcerates. We present a 12-year-old boy with diffuse persistent lip swelling mimicking granulomatous cheilitis. Systemic glucantime was started. However, severe hypotension and bradycardia was developed after injection. Oral fluconazole was started and the lesion resolved completely. Cutaneous leishmaniasis can have varied clinical manifestations and should be suspected especially in endemic areas. Oral fluconazole seems to be safe and effective treatment modality in paediatric cases.eninfo:eu-repo/semantics/closedAccessAntiprotozoal AgentsChildDiagnosis, DifferentialFluconazoleHumansLeishmaniasis, CutaneousLipMaleMeglumineMelkersson-Rosenthal SyndromeOrganometallic CompoundsTreatment Outcomeantiprotozoal agentfluconazolemegluminemeglumine antimoniateorganometallic compoundcase reportchilddifferential diagnosishumanLeishmaniasis, CutaneouslipmaleMelkersson-Rosenthal Syndromepathologytreatment outcomeArticle61319719910.17420/ap6103.08265689942-s2.0-85003049905Q4